| 1.7 |
6.8 |
GO:0072139 |
glomerular parietal epithelial cell differentiation(GO:0072139) |
| 1.5 |
12.4 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 1.4 |
4.3 |
GO:0072034 |
renal vesicle induction(GO:0072034) |
| 1.0 |
4.1 |
GO:1990535 |
neuron projection maintenance(GO:1990535) |
| 1.0 |
6.1 |
GO:1904381 |
Golgi apparatus mannose trimming(GO:1904381) |
| 1.0 |
1.0 |
GO:0010770 |
positive regulation of cell morphogenesis involved in differentiation(GO:0010770) |
| 1.0 |
11.6 |
GO:2000111 |
positive regulation of macrophage apoptotic process(GO:2000111) |
| 1.0 |
1.0 |
GO:0090114 |
COPII-coated vesicle budding(GO:0090114) |
| 0.9 |
0.9 |
GO:1903756 |
regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.9 |
2.6 |
GO:1990108 |
protein linear deubiquitination(GO:1990108) |
| 0.8 |
2.5 |
GO:1990927 |
calcium ion regulated lysosome exocytosis(GO:1990927) |
| 0.8 |
2.5 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 0.8 |
0.8 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.8 |
3.3 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.8 |
2.4 |
GO:0015817 |
histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
| 0.8 |
2.3 |
GO:0071109 |
superior temporal gyrus development(GO:0071109) |
| 0.8 |
3.1 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.7 |
3.0 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.7 |
2.2 |
GO:0097252 |
oligodendrocyte apoptotic process(GO:0097252) |
| 0.7 |
2.2 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.7 |
0.7 |
GO:1904674 |
positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.7 |
2.1 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.6 |
1.9 |
GO:0098937 |
dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.6 |
1.9 |
GO:1904020 |
regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.6 |
3.1 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.6 |
3.6 |
GO:0001757 |
somite specification(GO:0001757) |
| 0.6 |
1.8 |
GO:0031587 |
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.6 |
1.7 |
GO:0035604 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) |
| 0.6 |
1.7 |
GO:0061181 |
regulation of chondrocyte development(GO:0061181) |
| 0.6 |
0.6 |
GO:0009268 |
response to pH(GO:0009268) |
| 0.6 |
3.4 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.6 |
1.1 |
GO:0034059 |
response to anoxia(GO:0034059) |
| 0.6 |
2.3 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.6 |
1.7 |
GO:1904048 |
regulation of spontaneous neurotransmitter secretion(GO:1904048) |
| 0.5 |
2.6 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.5 |
1.6 |
GO:0003274 |
endocardial cushion fusion(GO:0003274) |
| 0.5 |
0.5 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.5 |
2.0 |
GO:1903721 |
regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.5 |
1.4 |
GO:0090076 |
relaxation of skeletal muscle(GO:0090076) |
| 0.5 |
2.4 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.5 |
1.4 |
GO:1900276 |
regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
| 0.4 |
1.3 |
GO:1900222 |
negative regulation of beta-amyloid clearance(GO:1900222) |
| 0.4 |
2.2 |
GO:0061031 |
endodermal digestive tract morphogenesis(GO:0061031) |
| 0.4 |
1.3 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.4 |
1.3 |
GO:0030505 |
inorganic diphosphate transport(GO:0030505) |
| 0.4 |
1.3 |
GO:0060279 |
regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 0.4 |
2.1 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.4 |
3.7 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.4 |
2.9 |
GO:0071233 |
cellular response to leucine(GO:0071233) |
| 0.4 |
1.6 |
GO:0002086 |
diaphragm contraction(GO:0002086) |
| 0.4 |
1.6 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 0.4 |
1.2 |
GO:0035470 |
positive regulation of vascular wound healing(GO:0035470) |
| 0.4 |
1.2 |
GO:0071418 |
cellular response to amine stimulus(GO:0071418) |
| 0.4 |
0.8 |
GO:0061043 |
regulation of vascular wound healing(GO:0061043) |
| 0.4 |
1.2 |
GO:1903697 |
negative regulation of microvillus assembly(GO:1903697) |
| 0.4 |
1.2 |
GO:0014740 |
negative regulation of muscle hyperplasia(GO:0014740) |
| 0.4 |
1.6 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.4 |
3.5 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.4 |
1.6 |
GO:2001151 |
regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 0.4 |
1.9 |
GO:0072014 |
proximal tubule development(GO:0072014) |
| 0.4 |
0.4 |
GO:0031016 |
pancreas development(GO:0031016) |
| 0.4 |
2.3 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.4 |
0.4 |
GO:2000466 |
negative regulation of glycogen (starch) synthase activity(GO:2000466) |
| 0.4 |
2.3 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.4 |
1.5 |
GO:0046271 |
phenylpropanoid catabolic process(GO:0046271) |
| 0.4 |
3.8 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.4 |
1.5 |
GO:1902613 |
regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 0.4 |
0.4 |
GO:0044752 |
response to human chorionic gonadotropin(GO:0044752) |
| 0.4 |
1.5 |
GO:1900224 |
positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.4 |
0.7 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.4 |
4.4 |
GO:0098887 |
neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
| 0.4 |
0.7 |
GO:1904886 |
beta-catenin destruction complex disassembly(GO:1904886) |
| 0.4 |
1.1 |
GO:1905072 |
apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) deltoid tuberosity development(GO:0035993) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) ureter morphogenesis(GO:0072197) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
| 0.4 |
4.7 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.4 |
1.8 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.4 |
2.1 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.4 |
1.1 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.4 |
1.1 |
GO:1901202 |
negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.4 |
0.4 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.4 |
0.7 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 0.4 |
2.1 |
GO:0010868 |
negative regulation of triglyceride biosynthetic process(GO:0010868) |
| 0.4 |
1.1 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.3 |
1.0 |
GO:0009138 |
pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 0.3 |
1.4 |
GO:0072134 |
nephrogenic mesenchyme morphogenesis(GO:0072134) |
| 0.3 |
2.1 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.3 |
0.7 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.3 |
1.7 |
GO:1903826 |
arginine transmembrane transport(GO:1903826) |
| 0.3 |
1.0 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.3 |
1.4 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 0.3 |
1.0 |
GO:0070839 |
divalent metal ion export(GO:0070839) |
| 0.3 |
3.4 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.3 |
2.7 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.3 |
0.7 |
GO:1905244 |
regulation of modification of synaptic structure(GO:1905244) |
| 0.3 |
0.3 |
GO:0070266 |
necroptotic process(GO:0070266) |
| 0.3 |
2.0 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.3 |
1.7 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.3 |
0.7 |
GO:0098727 |
maintenance of cell number(GO:0098727) |
| 0.3 |
1.0 |
GO:0046469 |
platelet activating factor metabolic process(GO:0046469) |
| 0.3 |
1.0 |
GO:1904328 |
regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.3 |
2.0 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.3 |
0.3 |
GO:0002437 |
inflammatory response to antigenic stimulus(GO:0002437) |
| 0.3 |
1.0 |
GO:0061394 |
regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.3 |
0.3 |
GO:0072076 |
nephrogenic mesenchyme development(GO:0072076) |
| 0.3 |
1.0 |
GO:0000294 |
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.3 |
3.6 |
GO:0045656 |
negative regulation of monocyte differentiation(GO:0045656) |
| 0.3 |
1.3 |
GO:1901355 |
response to rapamycin(GO:1901355) |
| 0.3 |
3.2 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.3 |
4.4 |
GO:0060453 |
regulation of gastric acid secretion(GO:0060453) |
| 0.3 |
1.6 |
GO:0009233 |
menaquinone metabolic process(GO:0009233) |
| 0.3 |
0.9 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.3 |
1.2 |
GO:1904199 |
positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
| 0.3 |
0.9 |
GO:0009726 |
detection of endogenous stimulus(GO:0009726) |
| 0.3 |
0.9 |
GO:0097477 |
lateral motor column neuron migration(GO:0097477) |
| 0.3 |
1.5 |
GO:0019470 |
4-hydroxyproline catabolic process(GO:0019470) |
| 0.3 |
0.6 |
GO:0003192 |
mitral valve formation(GO:0003192) |
| 0.3 |
2.1 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.3 |
1.2 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.3 |
5.4 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.3 |
0.6 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
| 0.3 |
1.2 |
GO:0072093 |
metanephric renal vesicle formation(GO:0072093) |
| 0.3 |
0.3 |
GO:1900168 |
glial cell-derived neurotrophic factor secretion(GO:0044467) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
| 0.3 |
5.1 |
GO:0003084 |
positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.3 |
0.9 |
GO:0021919 |
BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.3 |
1.5 |
GO:0009439 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.3 |
1.2 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.3 |
0.9 |
GO:0021503 |
neural fold bending(GO:0021503) |
| 0.3 |
1.4 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.3 |
1.1 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.3 |
1.4 |
GO:0061669 |
spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.3 |
0.9 |
GO:1905205 |
positive regulation of connective tissue replacement(GO:1905205) |
| 0.3 |
1.4 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.3 |
0.6 |
GO:0045925 |
positive regulation of female receptivity(GO:0045925) |
| 0.3 |
1.7 |
GO:0009450 |
gamma-aminobutyric acid catabolic process(GO:0009450) |
| 0.3 |
0.8 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.3 |
1.4 |
GO:0061107 |
seminal vesicle development(GO:0061107) |
| 0.3 |
0.8 |
GO:0035283 |
rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.3 |
1.4 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.3 |
1.1 |
GO:0097676 |
histone H3-K36 dimethylation(GO:0097676) |
| 0.3 |
1.4 |
GO:0035549 |
positive regulation of interferon-beta secretion(GO:0035549) |
| 0.3 |
1.4 |
GO:0021553 |
olfactory nerve development(GO:0021553) |
| 0.3 |
1.4 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.3 |
2.2 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.3 |
2.5 |
GO:2001300 |
lipoxin metabolic process(GO:2001300) |
| 0.3 |
1.9 |
GO:0014041 |
regulation of neuron maturation(GO:0014041) |
| 0.3 |
1.1 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.3 |
0.8 |
GO:0060999 |
positive regulation of dendritic spine development(GO:0060999) |
| 0.3 |
0.8 |
GO:0010748 |
regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 0.3 |
1.1 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.3 |
0.3 |
GO:0030201 |
heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.3 |
0.5 |
GO:2000272 |
negative regulation of receptor activity(GO:2000272) |
| 0.3 |
0.3 |
GO:0072053 |
renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 0.3 |
0.8 |
GO:1903762 |
positive regulation of actin filament-based movement(GO:1903116) positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
| 0.3 |
0.3 |
GO:0006497 |
protein lipidation(GO:0006497) lipoprotein metabolic process(GO:0042157) |
| 0.3 |
1.6 |
GO:0072180 |
mesonephric duct morphogenesis(GO:0072180) |
| 0.3 |
1.3 |
GO:0036369 |
transcription factor catabolic process(GO:0036369) |
| 0.3 |
0.8 |
GO:0051138 |
positive regulation of NK T cell differentiation(GO:0051138) |
| 0.3 |
1.9 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.3 |
0.3 |
GO:0042536 |
negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
| 0.3 |
0.3 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.3 |
0.5 |
GO:0072069 |
DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
| 0.3 |
0.8 |
GO:0086047 |
membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
| 0.3 |
0.3 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.3 |
0.8 |
GO:0044537 |
regulation of circulating fibrinogen levels(GO:0044537) |
| 0.3 |
1.8 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.3 |
2.1 |
GO:1903539 |
protein localization to postsynaptic membrane(GO:1903539) |
| 0.3 |
1.3 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.3 |
0.3 |
GO:1900169 |
regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.3 |
0.8 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.3 |
0.5 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.3 |
1.5 |
GO:0052551 |
response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.3 |
0.8 |
GO:0045074 |
interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
| 0.3 |
0.8 |
GO:0050902 |
leukocyte adhesive activation(GO:0050902) |
| 0.3 |
1.5 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.3 |
0.8 |
GO:1990180 |
mitochondrial tRNA 3'-end processing(GO:1990180) |
| 0.3 |
0.5 |
GO:0060157 |
urinary bladder development(GO:0060157) |
| 0.2 |
3.5 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.2 |
0.7 |
GO:0097360 |
chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.2 |
0.5 |
GO:0015886 |
heme transport(GO:0015886) iron coordination entity transport(GO:1901678) |
| 0.2 |
1.0 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.2 |
0.2 |
GO:0003133 |
BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) |
| 0.2 |
1.0 |
GO:0003219 |
cardiac right ventricle formation(GO:0003219) |
| 0.2 |
1.7 |
GO:0060992 |
response to fungicide(GO:0060992) |
| 0.2 |
0.7 |
GO:0034380 |
high-density lipoprotein particle assembly(GO:0034380) |
| 0.2 |
1.2 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.2 |
3.9 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.2 |
1.4 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.2 |
0.7 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.2 |
1.4 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.2 |
0.7 |
GO:0071529 |
cementum mineralization(GO:0071529) |
| 0.2 |
0.7 |
GO:0060086 |
circadian temperature homeostasis(GO:0060086) |
| 0.2 |
2.1 |
GO:0002414 |
immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 0.2 |
1.2 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) |
| 0.2 |
0.2 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.2 |
1.9 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.2 |
0.9 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 0.2 |
0.7 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.2 |
0.2 |
GO:0071874 |
response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
| 0.2 |
1.4 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.2 |
1.6 |
GO:0019086 |
late viral transcription(GO:0019086) |
| 0.2 |
0.5 |
GO:1902263 |
apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 0.2 |
0.9 |
GO:0090034 |
regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.2 |
1.4 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.2 |
0.2 |
GO:0033127 |
regulation of histone phosphorylation(GO:0033127) |
| 0.2 |
1.2 |
GO:0015692 |
lead ion transport(GO:0015692) |
| 0.2 |
2.3 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.2 |
0.7 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.2 |
1.6 |
GO:0090336 |
positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.2 |
0.7 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 0.2 |
0.5 |
GO:2001012 |
mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.2 |
0.5 |
GO:2001184 |
positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.2 |
0.5 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 0.2 |
0.7 |
GO:0042713 |
sperm ejaculation(GO:0042713) |
| 0.2 |
2.7 |
GO:0055089 |
fatty acid homeostasis(GO:0055089) |
| 0.2 |
1.1 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.2 |
0.9 |
GO:0002503 |
peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 0.2 |
0.7 |
GO:2000661 |
positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.2 |
0.7 |
GO:0010725 |
regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
| 0.2 |
0.7 |
GO:0015993 |
molecular hydrogen transport(GO:0015993) |
| 0.2 |
2.0 |
GO:0031444 |
slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.2 |
0.2 |
GO:0021603 |
cranial nerve formation(GO:0021603) |
| 0.2 |
1.1 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.2 |
0.9 |
GO:0042335 |
cuticle development(GO:0042335) |
| 0.2 |
0.7 |
GO:0009443 |
pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.2 |
0.4 |
GO:0097501 |
stress response to metal ion(GO:0097501) |
| 0.2 |
0.6 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.2 |
1.5 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.2 |
0.2 |
GO:1904322 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.2 |
1.3 |
GO:0071105 |
response to interleukin-11(GO:0071105) |
| 0.2 |
0.6 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 0.2 |
0.9 |
GO:0030311 |
poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.2 |
0.6 |
GO:1904397 |
negative regulation of neuromuscular junction development(GO:1904397) |
| 0.2 |
1.9 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.2 |
0.6 |
GO:0060823 |
canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
| 0.2 |
0.8 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.2 |
1.1 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.2 |
1.3 |
GO:1902731 |
negative regulation of chondrocyte proliferation(GO:1902731) |
| 0.2 |
0.2 |
GO:0072554 |
blood vessel lumenization(GO:0072554) |
| 0.2 |
0.4 |
GO:0009794 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.2 |
0.6 |
GO:0019056 |
modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 0.2 |
0.8 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.2 |
0.6 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.2 |
0.8 |
GO:0072299 |
visceral serous pericardium development(GO:0061032) posterior mesonephric tubule development(GO:0072166) negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
| 0.2 |
0.4 |
GO:0002931 |
response to ischemia(GO:0002931) |
| 0.2 |
0.8 |
GO:0042418 |
epinephrine biosynthetic process(GO:0042418) |
| 0.2 |
1.0 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.2 |
1.6 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 0.2 |
0.8 |
GO:0046671 |
negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.2 |
0.4 |
GO:0042733 |
embryonic digit morphogenesis(GO:0042733) |
| 0.2 |
1.0 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.2 |
0.8 |
GO:1900245 |
positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.2 |
2.8 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.2 |
7.9 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.2 |
0.6 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.2 |
1.0 |
GO:1903288 |
positive regulation of potassium ion import(GO:1903288) |
| 0.2 |
3.6 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.2 |
1.0 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.2 |
0.8 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.2 |
0.6 |
GO:2000721 |
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.2 |
0.4 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.2 |
0.8 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 0.2 |
3.5 |
GO:0010248 |
establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.2 |
0.6 |
GO:0043602 |
nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) |
| 0.2 |
1.0 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 0.2 |
0.6 |
GO:2000546 |
positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.2 |
0.4 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.2 |
0.8 |
GO:2000564 |
CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
| 0.2 |
0.8 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.2 |
0.4 |
GO:0006203 |
dGTP catabolic process(GO:0006203) |
| 0.2 |
0.4 |
GO:0001560 |
regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.2 |
0.6 |
GO:0042369 |
vitamin D catabolic process(GO:0042369) |
| 0.2 |
0.6 |
GO:1902161 |
positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
| 0.2 |
0.2 |
GO:0071284 |
cellular response to lead ion(GO:0071284) |
| 0.2 |
0.8 |
GO:0017198 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.2 |
1.5 |
GO:0045776 |
negative regulation of blood pressure(GO:0045776) |
| 0.2 |
0.4 |
GO:0046666 |
retinal cell programmed cell death(GO:0046666) |
| 0.2 |
0.6 |
GO:0016260 |
selenocysteine biosynthetic process(GO:0016260) |
| 0.2 |
0.2 |
GO:0050690 |
regulation of defense response to virus by virus(GO:0050690) |
| 0.2 |
0.2 |
GO:0045964 |
positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.2 |
0.9 |
GO:0032803 |
regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
| 0.2 |
1.3 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.2 |
2.0 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 0.2 |
1.6 |
GO:0042984 |
amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.2 |
1.3 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.2 |
0.7 |
GO:0005986 |
sucrose metabolic process(GO:0005985) sucrose biosynthetic process(GO:0005986) |
| 0.2 |
0.5 |
GO:0043324 |
eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.2 |
0.7 |
GO:0043323 |
regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.2 |
0.5 |
GO:1903691 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.2 |
0.2 |
GO:0040037 |
negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.2 |
0.5 |
GO:1903061 |
positive regulation of protein lipidation(GO:1903061) |
| 0.2 |
0.7 |
GO:2001288 |
positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.2 |
1.3 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.2 |
0.5 |
GO:0000472 |
endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.2 |
0.4 |
GO:1900242 |
regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.2 |
0.7 |
GO:0060313 |
negative regulation of blood vessel remodeling(GO:0060313) |
| 0.2 |
0.5 |
GO:0003408 |
optic cup formation involved in camera-type eye development(GO:0003408) |
| 0.2 |
2.0 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.2 |
1.3 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.2 |
0.4 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.2 |
0.7 |
GO:0060664 |
epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
| 0.2 |
1.8 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 0.2 |
2.5 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.2 |
2.8 |
GO:0070571 |
negative regulation of neuron projection regeneration(GO:0070571) |
| 0.2 |
1.8 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.2 |
2.5 |
GO:0098703 |
calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.2 |
0.5 |
GO:0042351 |
'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.2 |
0.4 |
GO:0060935 |
cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) |
| 0.2 |
3.9 |
GO:0006590 |
thyroid hormone generation(GO:0006590) |
| 0.2 |
1.8 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.2 |
0.2 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) |
| 0.2 |
1.2 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.2 |
0.2 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 0.2 |
1.0 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.2 |
1.7 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.2 |
0.3 |
GO:0048168 |
regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.2 |
0.9 |
GO:0038169 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.2 |
2.1 |
GO:1903012 |
positive regulation of bone development(GO:1903012) |
| 0.2 |
0.2 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.2 |
0.3 |
GO:0061289 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) metanephric nephron tubule morphogenesis(GO:0072282) |
| 0.2 |
2.9 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.2 |
2.2 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.2 |
1.4 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.2 |
5.0 |
GO:1904380 |
endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.2 |
2.0 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.2 |
0.7 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.2 |
0.3 |
GO:2000501 |
regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.2 |
0.7 |
GO:0033387 |
putrescine biosynthetic process from ornithine(GO:0033387) |
| 0.2 |
0.3 |
GO:0098712 |
L-glutamate import across plasma membrane(GO:0098712) |
| 0.2 |
0.2 |
GO:0007602 |
phototransduction(GO:0007602) |
| 0.2 |
0.7 |
GO:0072675 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.2 |
3.0 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.2 |
2.0 |
GO:1902659 |
regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.2 |
0.7 |
GO:0048073 |
regulation of eye pigmentation(GO:0048073) |
| 0.2 |
1.2 |
GO:0002031 |
G-protein coupled receptor internalization(GO:0002031) |
| 0.2 |
0.3 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.2 |
1.0 |
GO:0060263 |
regulation of respiratory burst(GO:0060263) |
| 0.2 |
0.7 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.2 |
0.5 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.2 |
0.2 |
GO:2000291 |
regulation of myoblast proliferation(GO:2000291) |
| 0.2 |
0.7 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.2 |
0.5 |
GO:1902303 |
negative regulation of potassium ion export(GO:1902303) |
| 0.2 |
1.1 |
GO:0035585 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 0.2 |
0.5 |
GO:1902075 |
cellular response to salt(GO:1902075) |
| 0.2 |
0.2 |
GO:0071340 |
skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.2 |
0.2 |
GO:1902954 |
regulation of early endosome to recycling endosome transport(GO:1902954) |
| 0.2 |
1.9 |
GO:0043406 |
positive regulation of MAP kinase activity(GO:0043406) |
| 0.2 |
1.1 |
GO:0034650 |
cortisol metabolic process(GO:0034650) cortisol biosynthetic process(GO:0034651) |
| 0.2 |
0.2 |
GO:0006929 |
substrate-dependent cell migration(GO:0006929) |
| 0.2 |
0.6 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.2 |
0.6 |
GO:0010266 |
response to vitamin B1(GO:0010266) |
| 0.2 |
1.3 |
GO:0003374 |
dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 0.2 |
1.3 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.2 |
4.2 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.2 |
1.8 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.2 |
0.5 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.2 |
0.2 |
GO:2000646 |
positive regulation of receptor catabolic process(GO:2000646) |
| 0.2 |
0.5 |
GO:1904760 |
myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 0.2 |
1.6 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 0.2 |
1.3 |
GO:0071316 |
cellular response to nicotine(GO:0071316) |
| 0.2 |
9.9 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.2 |
1.8 |
GO:2000696 |
regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
| 0.2 |
0.2 |
GO:0051066 |
dihydrobiopterin metabolic process(GO:0051066) |
| 0.2 |
0.6 |
GO:0043335 |
protein unfolding(GO:0043335) |
| 0.2 |
0.3 |
GO:0060449 |
bud elongation involved in lung branching(GO:0060449) |
| 0.2 |
0.8 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 0.2 |
0.2 |
GO:0010621 |
negative regulation of transcription by transcription factor localization(GO:0010621) |
| 0.2 |
0.5 |
GO:2000521 |
negative regulation of immunological synapse formation(GO:2000521) |
| 0.2 |
0.2 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.2 |
2.5 |
GO:0015866 |
ADP transport(GO:0015866) |
| 0.2 |
0.6 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.2 |
1.2 |
GO:0098706 |
ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.2 |
1.2 |
GO:2000852 |
corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
| 0.2 |
1.6 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.2 |
0.8 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.2 |
0.8 |
GO:0033184 |
positive regulation of histone ubiquitination(GO:0033184) regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.2 |
0.2 |
GO:0045658 |
regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.2 |
0.5 |
GO:0051758 |
homologous chromosome movement towards spindle pole involved in homologous chromosome segregation(GO:0051758) |
| 0.2 |
0.2 |
GO:0097343 |
ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.2 |
0.5 |
GO:0048243 |
norepinephrine secretion(GO:0048243) |
| 0.2 |
0.6 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.2 |
0.9 |
GO:1904209 |
regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 0.2 |
0.5 |
GO:0002143 |
tRNA wobble position uridine thiolation(GO:0002143) |
| 0.2 |
0.3 |
GO:0016999 |
antibiotic metabolic process(GO:0016999) |
| 0.2 |
0.6 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.2 |
0.2 |
GO:0036503 |
ERAD pathway(GO:0036503) |
| 0.2 |
0.9 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.2 |
0.5 |
GO:2001245 |
regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.2 |
0.3 |
GO:1990167 |
protein K27-linked deubiquitination(GO:1990167) |
| 0.2 |
0.3 |
GO:0003420 |
regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.1 |
1.5 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.1 |
3.6 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.1 |
1.8 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.1 |
8.3 |
GO:0099601 |
regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.1 |
1.9 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 0.1 |
0.6 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
| 0.1 |
0.1 |
GO:0060028 |
convergent extension involved in axis elongation(GO:0060028) |
| 0.1 |
1.3 |
GO:0070997 |
neuron death(GO:0070997) |
| 0.1 |
1.2 |
GO:0006880 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.1 |
1.9 |
GO:0010991 |
regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.1 |
0.6 |
GO:0035356 |
cellular triglyceride homeostasis(GO:0035356) |
| 0.1 |
0.7 |
GO:0097017 |
renal protein absorption(GO:0097017) |
| 0.1 |
0.3 |
GO:1902953 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.1 |
0.6 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.1 |
0.4 |
GO:0033629 |
negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.1 |
0.3 |
GO:1990834 |
response to odorant(GO:1990834) |
| 0.1 |
0.1 |
GO:0090212 |
regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.1 |
0.6 |
GO:0072429 |
response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.1 |
2.2 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.1 |
0.7 |
GO:0048505 |
regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 0.1 |
0.1 |
GO:2000506 |
negative regulation of energy homeostasis(GO:2000506) |
| 0.1 |
0.1 |
GO:0099638 |
endosome to plasma membrane protein transport(GO:0099638) |
| 0.1 |
0.6 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.1 |
5.4 |
GO:0090662 |
ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.1 |
0.1 |
GO:0070602 |
regulation of centromeric sister chromatid cohesion(GO:0070602) |
| 0.1 |
0.9 |
GO:0006021 |
inositol biosynthetic process(GO:0006021) |
| 0.1 |
1.0 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.1 |
2.3 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.1 |
1.0 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.1 |
0.6 |
GO:0097168 |
mesenchymal stem cell proliferation(GO:0097168) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.1 |
0.6 |
GO:1904016 |
response to Thyroglobulin triiodothyronine(GO:1904016) |
| 0.1 |
1.3 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.1 |
0.3 |
GO:0060425 |
lung morphogenesis(GO:0060425) |
| 0.1 |
0.4 |
GO:0038027 |
apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
| 0.1 |
1.3 |
GO:0042416 |
dopamine biosynthetic process(GO:0042416) |
| 0.1 |
1.4 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.1 |
1.1 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.1 |
1.5 |
GO:0002043 |
blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.1 |
0.8 |
GO:0048619 |
embryonic hindgut morphogenesis(GO:0048619) |
| 0.1 |
0.1 |
GO:0031443 |
fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 0.1 |
0.1 |
GO:0032717 |
negative regulation of interleukin-8 production(GO:0032717) |
| 0.1 |
0.7 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.1 |
1.1 |
GO:0008582 |
regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 0.1 |
0.5 |
GO:0016095 |
polyprenol catabolic process(GO:0016095) |
| 0.1 |
1.2 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.1 |
1.1 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.1 |
0.4 |
GO:0021644 |
vagus nerve morphogenesis(GO:0021644) chemorepulsion of branchiomotor axon(GO:0021793) |
| 0.1 |
1.2 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.1 |
0.3 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 0.1 |
0.8 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.1 |
0.5 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.1 |
0.4 |
GO:0097503 |
sialylation(GO:0097503) |
| 0.1 |
0.4 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.1 |
0.4 |
GO:1902741 |
interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.1 |
0.1 |
GO:0030522 |
intracellular receptor signaling pathway(GO:0030522) |
| 0.1 |
0.5 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.1 |
1.1 |
GO:0034446 |
substrate adhesion-dependent cell spreading(GO:0034446) |
| 0.1 |
0.7 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.1 |
0.1 |
GO:0061738 |
late endosomal microautophagy(GO:0061738) |
| 0.1 |
0.1 |
GO:0046051 |
UTP metabolic process(GO:0046051) |
| 0.1 |
0.3 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 0.1 |
0.4 |
GO:1900060 |
negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.1 |
0.5 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.1 |
0.1 |
GO:0051969 |
regulation of transmission of nerve impulse(GO:0051969) |
| 0.1 |
0.3 |
GO:0032097 |
positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
| 0.1 |
0.3 |
GO:0002268 |
follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 0.1 |
0.3 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.1 |
0.4 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.1 |
0.5 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.1 |
0.5 |
GO:0021756 |
striatum development(GO:0021756) |
| 0.1 |
0.5 |
GO:0033685 |
negative regulation of luteinizing hormone secretion(GO:0033685) |
| 0.1 |
1.7 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.1 |
0.4 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.1 |
0.5 |
GO:0060355 |
positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.1 |
0.1 |
GO:0006679 |
glucosylceramide biosynthetic process(GO:0006679) |
| 0.1 |
0.5 |
GO:2000973 |
regulation of pro-B cell differentiation(GO:2000973) |
| 0.1 |
0.1 |
GO:0045080 |
positive regulation of chemokine biosynthetic process(GO:0045080) |
| 0.1 |
0.4 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.1 |
0.9 |
GO:0002091 |
negative regulation of receptor internalization(GO:0002091) |
| 0.1 |
0.4 |
GO:0001573 |
ganglioside metabolic process(GO:0001573) |
| 0.1 |
1.0 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.1 |
0.4 |
GO:0051642 |
centrosome localization(GO:0051642) |
| 0.1 |
0.1 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.1 |
0.3 |
GO:0038162 |
erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.1 |
0.1 |
GO:0034776 |
response to histamine(GO:0034776) |
| 0.1 |
0.1 |
GO:0046330 |
positive regulation of JNK cascade(GO:0046330) |
| 0.1 |
3.1 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.1 |
1.9 |
GO:0006558 |
L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.1 |
0.2 |
GO:0061010 |
gall bladder development(GO:0061010) |
| 0.1 |
0.5 |
GO:0035026 |
leading edge cell differentiation(GO:0035026) |
| 0.1 |
1.5 |
GO:0031118 |
rRNA pseudouridine synthesis(GO:0031118) |
| 0.1 |
0.1 |
GO:0086091 |
regulation of heart rate by cardiac conduction(GO:0086091) |
| 0.1 |
0.4 |
GO:0035494 |
SNARE complex disassembly(GO:0035494) |
| 0.1 |
1.1 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.1 |
0.4 |
GO:1990258 |
box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.1 |
1.1 |
GO:1903748 |
negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
| 0.1 |
0.6 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.1 |
0.1 |
GO:0021772 |
olfactory bulb development(GO:0021772) |
| 0.1 |
1.0 |
GO:0006751 |
glutathione catabolic process(GO:0006751) |
| 0.1 |
1.2 |
GO:1900044 |
regulation of protein K63-linked ubiquitination(GO:1900044) |
| 0.1 |
0.2 |
GO:0002090 |
regulation of receptor internalization(GO:0002090) |
| 0.1 |
0.5 |
GO:1902715 |
positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.1 |
2.8 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.1 |
0.6 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.1 |
1.1 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.1 |
0.4 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.1 |
0.6 |
GO:0051195 |
negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.1 |
1.4 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.1 |
0.4 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.1 |
0.2 |
GO:0014878 |
response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 0.1 |
0.4 |
GO:0001994 |
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.1 |
2.4 |
GO:1904714 |
regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.1 |
0.2 |
GO:0016246 |
RNA interference(GO:0016246) |
| 0.1 |
0.1 |
GO:0035625 |
epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.1 |
0.5 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.1 |
0.1 |
GO:0032231 |
regulation of actin filament bundle assembly(GO:0032231) |
| 0.1 |
0.3 |
GO:0042727 |
flavin-containing compound biosynthetic process(GO:0042727) |
| 0.1 |
2.3 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.1 |
0.3 |
GO:0050893 |
sensory processing(GO:0050893) |
| 0.1 |
0.1 |
GO:0071421 |
manganese ion transmembrane transport(GO:0071421) |
| 0.1 |
0.3 |
GO:1903347 |
negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.1 |
0.3 |
GO:0032290 |
peripheral nervous system myelin formation(GO:0032290) |
| 0.1 |
0.1 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.1 |
0.1 |
GO:0071711 |
basement membrane organization(GO:0071711) |
| 0.1 |
0.1 |
GO:2000118 |
regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.1 |
1.4 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
0.1 |
GO:0045113 |
regulation of integrin biosynthetic process(GO:0045113) |
| 0.1 |
2.2 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.1 |
0.8 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.1 |
0.6 |
GO:0036493 |
positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.1 |
0.2 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.1 |
1.0 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.1 |
0.9 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 0.1 |
0.3 |
GO:2000074 |
regulation of type B pancreatic cell development(GO:2000074) |
| 0.1 |
1.7 |
GO:0090360 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.1 |
0.3 |
GO:0060372 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 0.1 |
0.8 |
GO:0038110 |
interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.1 |
2.0 |
GO:0001682 |
tRNA 5'-leader removal(GO:0001682) |
| 0.1 |
0.4 |
GO:0009597 |
detection of virus(GO:0009597) |
| 0.1 |
0.7 |
GO:0045670 |
regulation of osteoclast differentiation(GO:0045670) |
| 0.1 |
0.3 |
GO:0001172 |
transcription, RNA-templated(GO:0001172) |
| 0.1 |
0.1 |
GO:0051140 |
regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
| 0.1 |
1.1 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.1 |
0.5 |
GO:0019369 |
arachidonic acid metabolic process(GO:0019369) |
| 0.1 |
0.4 |
GO:0045875 |
negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.1 |
2.4 |
GO:0051770 |
positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.1 |
0.1 |
GO:2001137 |
positive regulation of endocytic recycling(GO:2001137) |
| 0.1 |
0.9 |
GO:0042659 |
regulation of cell fate specification(GO:0042659) |
| 0.1 |
0.3 |
GO:1904578 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 0.1 |
0.2 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.1 |
0.4 |
GO:0061034 |
olfactory bulb mitral cell layer development(GO:0061034) |
| 0.1 |
0.3 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.1 |
0.5 |
GO:1901090 |
regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.1 |
0.4 |
GO:1904627 |
response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.1 |
1.9 |
GO:1902235 |
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
| 0.1 |
1.3 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.1 |
0.3 |
GO:0034140 |
negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
| 0.1 |
0.2 |
GO:0050717 |
positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.1 |
0.5 |
GO:0006127 |
glycerophosphate shuttle(GO:0006127) |
| 0.1 |
0.2 |
GO:1902230 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.1 |
1.0 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.1 |
0.3 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.1 |
3.0 |
GO:0060117 |
auditory receptor cell development(GO:0060117) |
| 0.1 |
0.7 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.1 |
0.7 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.1 |
2.6 |
GO:2001275 |
positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.1 |
0.1 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 0.1 |
1.5 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.1 |
0.8 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.1 |
2.2 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.1 |
0.4 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) |
| 0.1 |
0.4 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 |
0.1 |
GO:1903625 |
negative regulation of DNA catabolic process(GO:1903625) |
| 0.1 |
0.4 |
GO:0008045 |
motor neuron axon guidance(GO:0008045) |
| 0.1 |
1.5 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.1 |
0.3 |
GO:2000687 |
negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.1 |
0.1 |
GO:0072050 |
S-shaped body morphogenesis(GO:0072050) |
| 0.1 |
0.1 |
GO:1903490 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.1 |
2.0 |
GO:0006337 |
nucleosome disassembly(GO:0006337) |
| 0.1 |
0.7 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.1 |
0.3 |
GO:2001033 |
negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.1 |
1.2 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 |
0.2 |
GO:1905123 |
regulation of glucosylceramidase activity(GO:1905123) |
| 0.1 |
0.2 |
GO:0051563 |
smooth endoplasmic reticulum calcium ion homeostasis(GO:0051563) |
| 0.1 |
0.5 |
GO:0060137 |
maternal process involved in parturition(GO:0060137) |
| 0.1 |
0.7 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 |
0.7 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.1 |
0.1 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.1 |
0.3 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.1 |
2.5 |
GO:0045332 |
phospholipid translocation(GO:0045332) |
| 0.1 |
0.7 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.1 |
0.1 |
GO:0014060 |
regulation of epinephrine secretion(GO:0014060) epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
| 0.1 |
0.2 |
GO:0045348 |
positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.1 |
0.1 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.1 |
0.9 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
| 0.1 |
0.5 |
GO:0042415 |
norepinephrine metabolic process(GO:0042415) |
| 0.1 |
0.5 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.1 |
0.5 |
GO:0006121 |
mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.1 |
1.1 |
GO:2000304 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.1 |
1.0 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.1 |
1.9 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.1 |
0.4 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.1 |
0.1 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.1 |
0.4 |
GO:0043128 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.1 |
0.4 |
GO:0097152 |
mesenchymal cell apoptotic process(GO:0097152) |
| 0.1 |
2.2 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) |
| 0.1 |
0.2 |
GO:0045645 |
regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.1 |
1.0 |
GO:0019317 |
fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.1 |
0.3 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
| 0.1 |
0.3 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 |
0.1 |
GO:0035802 |
adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) |
| 0.1 |
0.2 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 0.1 |
0.3 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 |
3.0 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 0.1 |
0.4 |
GO:0097068 |
response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
| 0.1 |
0.6 |
GO:1900239 |
phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.1 |
0.2 |
GO:2001252 |
positive regulation of chromosome organization(GO:2001252) |
| 0.1 |
0.4 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.1 |
0.3 |
GO:0050823 |
peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
| 0.1 |
0.2 |
GO:0060352 |
cell adhesion molecule production(GO:0060352) |
| 0.1 |
0.8 |
GO:0046349 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) amino sugar biosynthetic process(GO:0046349) |
| 0.1 |
1.2 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
| 0.1 |
1.2 |
GO:2000772 |
regulation of cellular senescence(GO:2000772) |
| 0.1 |
0.2 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.1 |
0.1 |
GO:0071926 |
endocannabinoid signaling pathway(GO:0071926) |
| 0.1 |
0.3 |
GO:1902910 |
regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) regulation of melanosome transport(GO:1902908) positive regulation of melanosome transport(GO:1902910) |
| 0.1 |
0.2 |
GO:0030885 |
regulation of myeloid dendritic cell activation(GO:0030885) negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 0.1 |
0.1 |
GO:0044828 |
negative regulation by host of viral genome replication(GO:0044828) |
| 0.1 |
3.1 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.1 |
0.5 |
GO:0035799 |
ureter maturation(GO:0035799) |
| 0.1 |
1.6 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 |
0.4 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.1 |
0.6 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
| 0.1 |
0.2 |
GO:0021650 |
vestibulocochlear nerve formation(GO:0021650) |
| 0.1 |
0.1 |
GO:0009946 |
proximal/distal axis specification(GO:0009946) |
| 0.1 |
0.7 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.1 |
0.4 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.1 |
0.8 |
GO:0002191 |
cap-dependent translational initiation(GO:0002191) |
| 0.1 |
0.2 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) |
| 0.1 |
0.2 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.1 |
0.1 |
GO:0070666 |
regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
| 0.1 |
1.1 |
GO:0000479 |
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
| 0.1 |
0.8 |
GO:2000622 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 |
0.4 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.1 |
0.4 |
GO:0003214 |
cardiac left ventricle morphogenesis(GO:0003214) |
| 0.1 |
1.1 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.1 |
0.8 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.1 |
0.2 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.1 |
0.3 |
GO:0032637 |
interleukin-8 production(GO:0032637) |
| 0.1 |
0.1 |
GO:0035791 |
platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 0.1 |
0.1 |
GO:0072178 |
nephric duct morphogenesis(GO:0072178) |
| 0.1 |
0.8 |
GO:0071415 |
cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
| 0.1 |
0.2 |
GO:0030047 |
actin modification(GO:0030047) |
| 0.1 |
0.1 |
GO:0031630 |
regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.1 |
4.7 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.1 |
0.1 |
GO:1903526 |
negative regulation of membrane tubulation(GO:1903526) |
| 0.1 |
0.8 |
GO:0072189 |
ureter development(GO:0072189) |
| 0.1 |
0.3 |
GO:0044381 |
glucose import in response to insulin stimulus(GO:0044381) |
| 0.1 |
1.1 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.1 |
0.2 |
GO:0016102 |
retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
| 0.1 |
0.7 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.1 |
0.2 |
GO:1900369 |
negative regulation of RNA interference(GO:1900369) |
| 0.1 |
1.4 |
GO:0090005 |
negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.1 |
0.3 |
GO:0010816 |
neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.1 |
1.2 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.1 |
0.9 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.1 |
1.8 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.1 |
0.3 |
GO:1902361 |
mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.1 |
0.3 |
GO:0071934 |
thiamine transmembrane transport(GO:0071934) |
| 0.1 |
0.4 |
GO:0035995 |
detection of muscle stretch(GO:0035995) |
| 0.1 |
0.2 |
GO:0080154 |
regulation of fertilization(GO:0080154) |
| 0.1 |
0.6 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 |
0.3 |
GO:0051102 |
DNA ligation involved in DNA recombination(GO:0051102) |
| 0.1 |
0.2 |
GO:0021558 |
trochlear nerve development(GO:0021558) |
| 0.1 |
0.2 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.1 |
0.3 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.1 |
0.3 |
GO:1903659 |
regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.1 |
1.6 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.1 |
0.5 |
GO:0006616 |
SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.1 |
0.1 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.1 |
0.5 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 0.1 |
0.4 |
GO:1901838 |
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.1 |
0.2 |
GO:0035879 |
plasma membrane lactate transport(GO:0035879) |
| 0.1 |
0.2 |
GO:0034239 |
macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
| 0.1 |
0.1 |
GO:0014805 |
smooth muscle adaptation(GO:0014805) |
| 0.1 |
2.2 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.1 |
0.3 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.1 |
0.1 |
GO:0019401 |
glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
| 0.1 |
0.1 |
GO:0014075 |
response to amine(GO:0014075) |
| 0.1 |
0.3 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.1 |
0.2 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.1 |
0.3 |
GO:0090299 |
regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.1 |
1.3 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 |
0.3 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.1 |
0.5 |
GO:0045408 |
regulation of interleukin-6 biosynthetic process(GO:0045408) |
| 0.1 |
0.3 |
GO:2000553 |
positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
| 0.1 |
1.5 |
GO:0018146 |
keratan sulfate biosynthetic process(GO:0018146) |
| 0.1 |
3.3 |
GO:0051973 |
positive regulation of telomerase activity(GO:0051973) |
| 0.1 |
0.3 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.1 |
0.2 |
GO:1900073 |
regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.1 |
0.4 |
GO:1902412 |
regulation of mitotic cytokinesis(GO:1902412) |
| 0.1 |
0.8 |
GO:0042635 |
positive regulation of hair cycle(GO:0042635) |
| 0.1 |
0.6 |
GO:0033599 |
regulation of mammary gland epithelial cell proliferation(GO:0033599) |
| 0.1 |
0.3 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.1 |
0.2 |
GO:0071219 |
cellular response to molecule of bacterial origin(GO:0071219) |
| 0.1 |
0.1 |
GO:0009146 |
purine nucleoside triphosphate catabolic process(GO:0009146) |
| 0.1 |
1.0 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.1 |
0.1 |
GO:0033686 |
positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.1 |
1.4 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 |
0.3 |
GO:0018032 |
protein amidation(GO:0018032) |
| 0.1 |
0.3 |
GO:0051037 |
regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.1 |
0.3 |
GO:0015783 |
GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.1 |
0.1 |
GO:0060290 |
transdifferentiation(GO:0060290) |
| 0.1 |
0.1 |
GO:1904896 |
ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.1 |
0.2 |
GO:0022401 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.1 |
0.1 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.1 |
1.2 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.1 |
0.7 |
GO:0032264 |
IMP salvage(GO:0032264) |
| 0.1 |
0.4 |
GO:0071051 |
snoRNA 3'-end processing(GO:0031126) polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.1 |
0.4 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.1 |
0.6 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.1 |
0.2 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.1 |
0.2 |
GO:0009386 |
translational attenuation(GO:0009386) |
| 0.1 |
0.3 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
| 0.1 |
0.1 |
GO:1902373 |
negative regulation of mRNA catabolic process(GO:1902373) |
| 0.1 |
0.2 |
GO:0060897 |
neural plate regionalization(GO:0060897) |
| 0.1 |
0.6 |
GO:0097150 |
neuronal stem cell population maintenance(GO:0097150) |
| 0.1 |
0.2 |
GO:0042137 |
sequestering of neurotransmitter(GO:0042137) |
| 0.1 |
0.2 |
GO:0030969 |
mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.1 |
0.2 |
GO:0051167 |
glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.1 |
0.3 |
GO:0036269 |
swimming behavior(GO:0036269) |
| 0.1 |
0.5 |
GO:0098828 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.1 |
0.2 |
GO:1902473 |
regulation of protein localization to synapse(GO:1902473) |
| 0.1 |
0.3 |
GO:0015722 |
canalicular bile acid transport(GO:0015722) |
| 0.1 |
0.9 |
GO:0042574 |
retinal metabolic process(GO:0042574) |
| 0.1 |
1.3 |
GO:0060669 |
embryonic placenta morphogenesis(GO:0060669) |
| 0.1 |
1.9 |
GO:0060395 |
SMAD protein signal transduction(GO:0060395) |
| 0.1 |
0.4 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.1 |
0.1 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.1 |
1.1 |
GO:0035090 |
maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.1 |
1.0 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.1 |
0.6 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
1.3 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.1 |
2.4 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.1 |
0.3 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.1 |
0.1 |
GO:0014050 |
negative regulation of glutamate secretion(GO:0014050) |
| 0.1 |
0.4 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.1 |
0.6 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 |
0.1 |
GO:0010635 |
regulation of mitochondrial fusion(GO:0010635) |
| 0.1 |
0.7 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.1 |
0.3 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.1 |
2.3 |
GO:0071480 |
cellular response to gamma radiation(GO:0071480) |
| 0.1 |
0.3 |
GO:0052405 |
negative regulation by host of symbiont molecular function(GO:0052405) |
| 0.1 |
0.3 |
GO:2001034 |
positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.1 |
0.1 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.1 |
0.7 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.1 |
0.1 |
GO:0071286 |
cellular response to magnesium ion(GO:0071286) |
| 0.1 |
0.1 |
GO:1901655 |
cellular response to ketone(GO:1901655) |
| 0.1 |
0.7 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.1 |
0.2 |
GO:0060644 |
mammary gland epithelial cell differentiation(GO:0060644) |
| 0.1 |
0.4 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.1 |
0.2 |
GO:0021555 |
midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.1 |
0.1 |
GO:0015867 |
ATP transport(GO:0015867) |
| 0.1 |
1.3 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 |
0.5 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.1 |
0.1 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.1 |
0.7 |
GO:0035751 |
regulation of lysosomal lumen pH(GO:0035751) |
| 0.1 |
0.7 |
GO:0034398 |
telomere tethering at nuclear periphery(GO:0034398) |
| 0.1 |
0.1 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.1 |
0.1 |
GO:0017186 |
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.1 |
0.1 |
GO:0045226 |
extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.1 |
0.2 |
GO:2000449 |
CD8-positive, alpha-beta T cell extravasation(GO:0035697) CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) T cell extravasation(GO:0072683) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.1 |
0.4 |
GO:0060737 |
prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
| 0.1 |
0.1 |
GO:1904954 |
canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
| 0.1 |
0.1 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 0.1 |
1.5 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 |
0.3 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.1 |
2.6 |
GO:1904837 |
beta-catenin-TCF complex assembly(GO:1904837) |
| 0.1 |
0.4 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 |
0.3 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.1 |
0.8 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 |
0.3 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.1 |
0.4 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 |
2.3 |
GO:1904659 |
hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.1 |
0.3 |
GO:0043974 |
histone H3-K27 acetylation(GO:0043974) response to methylglyoxal(GO:0051595) regulation of histone H3-K27 acetylation(GO:1901674) negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.1 |
0.2 |
GO:1990785 |
initiation of primordial ovarian follicle growth(GO:0001544) response to water-immersion restraint stress(GO:1990785) |
| 0.1 |
0.4 |
GO:0032479 |
regulation of type I interferon production(GO:0032479) |
| 0.1 |
0.9 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.1 |
0.6 |
GO:0033327 |
Leydig cell differentiation(GO:0033327) |
| 0.1 |
0.1 |
GO:0000303 |
response to superoxide(GO:0000303) |
| 0.1 |
0.4 |
GO:0071481 |
cellular response to X-ray(GO:0071481) |
| 0.1 |
0.5 |
GO:0071816 |
tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.1 |
0.2 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.1 |
0.1 |
GO:0003338 |
metanephros morphogenesis(GO:0003338) |
| 0.1 |
0.3 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.1 |
0.4 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 0.1 |
2.4 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 |
0.7 |
GO:0010447 |
response to acidic pH(GO:0010447) |
| 0.1 |
1.8 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.1 |
0.2 |
GO:1902177 |
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.1 |
0.2 |
GO:0021591 |
ventricular system development(GO:0021591) |
| 0.1 |
0.1 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.1 |
0.7 |
GO:1901409 |
positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.1 |
0.3 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.1 |
0.2 |
GO:0071453 |
cellular response to oxygen levels(GO:0071453) |
| 0.1 |
0.1 |
GO:1903630 |
regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.1 |
0.2 |
GO:0035281 |
pre-miRNA export from nucleus(GO:0035281) |
| 0.1 |
1.1 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 |
1.4 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.1 |
0.5 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.1 |
1.1 |
GO:0048011 |
neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 0.1 |
0.6 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.1 |
0.3 |
GO:0006848 |
pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.1 |
0.7 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.1 |
0.3 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.1 |
0.1 |
GO:0002154 |
thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.1 |
0.6 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.1 |
0.5 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.1 |
0.2 |
GO:1902530 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.1 |
0.5 |
GO:1904816 |
positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.1 |
0.2 |
GO:0042494 |
detection of bacterial lipoprotein(GO:0042494) |
| 0.1 |
0.3 |
GO:0060536 |
cartilage morphogenesis(GO:0060536) |
| 0.1 |
0.6 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
0.1 |
GO:0002625 |
regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.1 |
0.1 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.1 |
1.0 |
GO:0090023 |
positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.1 |
1.8 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 |
0.1 |
GO:0061684 |
chaperone-mediated autophagy(GO:0061684) |
| 0.1 |
0.1 |
GO:1902299 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.1 |
0.3 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.1 |
0.4 |
GO:0032057 |
negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.1 |
0.6 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.1 |
0.1 |
GO:0048203 |
vesicle targeting, trans-Golgi to endosome(GO:0048203) |
| 0.1 |
0.3 |
GO:0014826 |
vein smooth muscle contraction(GO:0014826) |
| 0.1 |
0.2 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 |
0.1 |
GO:1903071 |
positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.1 |
0.2 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.1 |
0.7 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.1 |
0.2 |
GO:2001286 |
regulation of caveolin-mediated endocytosis(GO:2001286) |
| 0.1 |
0.5 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
| 0.1 |
0.4 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.1 |
0.1 |
GO:1903939 |
regulation of TORC2 signaling(GO:1903939) |
| 0.1 |
0.4 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.1 |
5.1 |
GO:0006487 |
protein N-linked glycosylation(GO:0006487) |
| 0.1 |
0.1 |
GO:0034397 |
telomere localization(GO:0034397) chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
| 0.1 |
0.2 |
GO:0046338 |
phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.1 |
0.3 |
GO:1901623 |
regulation of lymphocyte chemotaxis(GO:1901623) |
| 0.1 |
0.5 |
GO:2000010 |
positive regulation of protein localization to cell surface(GO:2000010) |
| 0.1 |
0.2 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.1 |
0.1 |
GO:0003222 |
ventricular trabecula myocardium morphogenesis(GO:0003222) |
| 0.1 |
0.6 |
GO:1900364 |
negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.1 |
0.5 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 |
0.1 |
GO:0039019 |
pronephric nephron development(GO:0039019) |
| 0.1 |
0.2 |
GO:0006433 |
prolyl-tRNA aminoacylation(GO:0006433) |
| 0.1 |
0.6 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.1 |
0.1 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) |
| 0.1 |
0.4 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.1 |
0.2 |
GO:0097254 |
renal tubular secretion(GO:0097254) |
| 0.1 |
0.2 |
GO:0051958 |
methotrexate transport(GO:0051958) |
| 0.1 |
0.4 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.1 |
0.7 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 0.1 |
0.6 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 |
0.5 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.1 |
0.4 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.1 |
0.5 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
| 0.1 |
0.8 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.1 |
0.7 |
GO:0007530 |
sex determination(GO:0007530) |
| 0.1 |
0.3 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.1 |
0.2 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.1 |
0.9 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.1 |
0.2 |
GO:0043570 |
maintenance of DNA repeat elements(GO:0043570) |
| 0.1 |
0.3 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.1 |
0.3 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.1 |
0.2 |
GO:0006423 |
cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.1 |
0.3 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.1 |
0.1 |
GO:0040031 |
snRNA modification(GO:0040031) |
| 0.1 |
0.1 |
GO:0035357 |
peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
| 0.1 |
0.1 |
GO:0032470 |
positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
| 0.1 |
0.1 |
GO:0060576 |
intestinal epithelial cell development(GO:0060576) |
| 0.1 |
0.1 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.1 |
0.4 |
GO:0007249 |
I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
| 0.1 |
0.3 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.1 |
0.1 |
GO:0048820 |
hair follicle maturation(GO:0048820) |
| 0.1 |
0.6 |
GO:1990314 |
cellular response to insulin-like growth factor stimulus(GO:1990314) |
| 0.1 |
0.7 |
GO:0021924 |
cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
| 0.1 |
0.2 |
GO:0072334 |
UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.1 |
0.4 |
GO:0051446 |
positive regulation of meiotic cell cycle(GO:0051446) |
| 0.1 |
0.2 |
GO:0050760 |
negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.1 |
0.7 |
GO:0098915 |
membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
| 0.1 |
0.1 |
GO:0034970 |
histone H3-R2 methylation(GO:0034970) |
| 0.1 |
0.1 |
GO:0010716 |
negative regulation of extracellular matrix disassembly(GO:0010716) |
| 0.1 |
0.2 |
GO:0090646 |
mitochondrial tRNA processing(GO:0090646) |
| 0.1 |
0.1 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.1 |
0.1 |
GO:0070365 |
hepatocyte differentiation(GO:0070365) |
| 0.1 |
0.2 |
GO:0022404 |
molting cycle process(GO:0022404) hair cycle process(GO:0022405) |
| 0.1 |
0.2 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 |
0.1 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.1 |
0.2 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.1 |
0.3 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.1 |
0.3 |
GO:0001921 |
positive regulation of receptor recycling(GO:0001921) |
| 0.1 |
1.1 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 |
0.8 |
GO:0072512 |
ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
| 0.1 |
0.2 |
GO:0001971 |
negative regulation of activation of membrane attack complex(GO:0001971) |
| 0.1 |
0.1 |
GO:0090310 |
negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
| 0.1 |
0.4 |
GO:0007567 |
parturition(GO:0007567) |
| 0.1 |
0.7 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.1 |
0.5 |
GO:0010898 |
positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.1 |
0.2 |
GO:0009698 |
phenylpropanoid metabolic process(GO:0009698) |
| 0.1 |
0.2 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.1 |
0.5 |
GO:0006552 |
leucine catabolic process(GO:0006552) |
| 0.1 |
0.2 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.1 |
0.2 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.1 |
0.7 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.1 |
0.1 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.1 |
0.3 |
GO:0060482 |
lobar bronchus development(GO:0060482) |
| 0.1 |
0.1 |
GO:0030316 |
osteoclast differentiation(GO:0030316) |
| 0.1 |
1.0 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.1 |
0.8 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 0.1 |
4.2 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.1 |
0.1 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.1 |
0.9 |
GO:0007616 |
long-term memory(GO:0007616) |
| 0.1 |
0.2 |
GO:1901052 |
sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.1 |
0.2 |
GO:1900118 |
negative regulation of execution phase of apoptosis(GO:1900118) |
| 0.1 |
0.2 |
GO:0006311 |
meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
| 0.1 |
0.3 |
GO:0042340 |
keratan sulfate catabolic process(GO:0042340) |
| 0.1 |
0.4 |
GO:0032776 |
DNA methylation on cytosine(GO:0032776) |
| 0.0 |
0.0 |
GO:0090269 |
fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
| 0.0 |
0.2 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.0 |
0.1 |
GO:0002296 |
T-helper 1 cell lineage commitment(GO:0002296) |
| 0.0 |
0.0 |
GO:0003419 |
growth plate cartilage chondrocyte proliferation(GO:0003419) |
| 0.0 |
0.9 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.0 |
0.6 |
GO:0030202 |
heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.0 |
0.1 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 |
0.1 |
GO:0002528 |
regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.0 |
1.7 |
GO:1902475 |
L-alpha-amino acid transmembrane transport(GO:1902475) |
| 0.0 |
0.4 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.0 |
0.1 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.0 |
0.9 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.0 |
0.1 |
GO:0060044 |
negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.0 |
0.1 |
GO:0010133 |
proline catabolic process to glutamate(GO:0010133) |
| 0.0 |
0.2 |
GO:0021694 |
cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.0 |
0.1 |
GO:0001714 |
endodermal cell fate specification(GO:0001714) |
| 0.0 |
0.3 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.0 |
0.3 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.0 |
0.2 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.0 |
0.1 |
GO:0042762 |
regulation of sulfur metabolic process(GO:0042762) |
| 0.0 |
0.2 |
GO:0061084 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) regulation of protein folding(GO:1903332) |
| 0.0 |
0.1 |
GO:0051592 |
response to calcium ion(GO:0051592) |
| 0.0 |
0.2 |
GO:0060312 |
regulation of blood vessel remodeling(GO:0060312) |
| 0.0 |
0.6 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.0 |
0.5 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.0 |
0.1 |
GO:0071895 |
odontoblast differentiation(GO:0071895) |
| 0.0 |
0.2 |
GO:0032239 |
regulation of nucleobase-containing compound transport(GO:0032239) |
| 0.0 |
0.1 |
GO:0045898 |
regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.0 |
0.3 |
GO:0034088 |
maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.0 |
0.0 |
GO:0046500 |
S-adenosylmethionine metabolic process(GO:0046500) |
| 0.0 |
0.2 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.0 |
0.1 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.0 |
0.2 |
GO:0030423 |
targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.0 |
0.3 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.0 |
0.1 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.0 |
0.4 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.0 |
0.1 |
GO:0000706 |
meiotic DNA double-strand break processing(GO:0000706) |
| 0.0 |
0.2 |
GO:1904044 |
response to aldosterone(GO:1904044) |
| 0.0 |
0.5 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
0.3 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.0 |
0.8 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.0 |
0.3 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.0 |
0.7 |
GO:0048265 |
response to pain(GO:0048265) |
| 0.0 |
0.3 |
GO:0019336 |
phenol-containing compound catabolic process(GO:0019336) |
| 0.0 |
0.2 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.0 |
0.4 |
GO:0045124 |
regulation of bone resorption(GO:0045124) |
| 0.0 |
0.8 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.0 |
0.3 |
GO:0090230 |
regulation of centromere complex assembly(GO:0090230) |
| 0.0 |
0.0 |
GO:0035883 |
enteroendocrine cell differentiation(GO:0035883) |
| 0.0 |
1.0 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 |
0.4 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.0 |
0.1 |
GO:2000479 |
regulation of cAMP-dependent protein kinase activity(GO:2000479) |
| 0.0 |
0.2 |
GO:1900738 |
positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.0 |
0.1 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 0.0 |
0.2 |
GO:0014889 |
muscle atrophy(GO:0014889) |
| 0.0 |
0.3 |
GO:0021794 |
thalamus development(GO:0021794) |
| 0.0 |
0.1 |
GO:0072506 |
phosphate ion homeostasis(GO:0055062) trivalent inorganic anion homeostasis(GO:0072506) |
| 0.0 |
4.0 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.0 |
0.1 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.0 |
0.0 |
GO:1900452 |
regulation of long term synaptic depression(GO:1900452) |
| 0.0 |
0.1 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.0 |
0.2 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in DNA damage checkpoint(GO:0072422) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
| 0.0 |
0.0 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.0 |
0.4 |
GO:0044818 |
mitotic G2/M transition checkpoint(GO:0044818) |
| 0.0 |
0.2 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.0 |
0.5 |
GO:0090501 |
RNA phosphodiester bond hydrolysis(GO:0090501) |
| 0.0 |
0.2 |
GO:0043032 |
positive regulation of macrophage activation(GO:0043032) |
| 0.0 |
0.5 |
GO:0098787 |
mRNA cleavage involved in mRNA processing(GO:0098787) |
| 0.0 |
0.4 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.0 |
0.2 |
GO:1903507 |
negative regulation of RNA biosynthetic process(GO:1902679) negative regulation of nucleic acid-templated transcription(GO:1903507) |
| 0.0 |
0.0 |
GO:2001140 |
regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
| 0.0 |
0.8 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.0 |
0.0 |
GO:1990637 |
response to prolactin(GO:1990637) |
| 0.0 |
0.1 |
GO:0060976 |
coronary vasculature development(GO:0060976) |
| 0.0 |
0.4 |
GO:1903846 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.0 |
0.0 |
GO:0002277 |
myeloid dendritic cell activation involved in immune response(GO:0002277) |
| 0.0 |
0.1 |
GO:1904106 |
protein localization to microvillus(GO:1904106) |
| 0.0 |
0.3 |
GO:1902175 |
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
| 0.0 |
0.3 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.0 |
0.2 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.0 |
0.3 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 |
1.2 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 0.0 |
0.1 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.0 |
0.1 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.0 |
0.0 |
GO:0032618 |
interleukin-15 production(GO:0032618) |
| 0.0 |
0.1 |
GO:0006681 |
galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
| 0.0 |
0.1 |
GO:0072203 |
cell proliferation involved in metanephros development(GO:0072203) |
| 0.0 |
0.0 |
GO:0021569 |
rhombomere 3 development(GO:0021569) |
| 0.0 |
1.0 |
GO:1903861 |
positive regulation of dendrite extension(GO:1903861) |
| 0.0 |
0.0 |
GO:1902897 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.0 |
0.1 |
GO:0043385 |
mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
| 0.0 |
0.5 |
GO:0071880 |
adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.0 |
0.2 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.0 |
0.3 |
GO:0035810 |
positive regulation of urine volume(GO:0035810) |
| 0.0 |
0.1 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.0 |
0.1 |
GO:0032972 |
regulation of muscle filament sliding speed(GO:0032972) |
| 0.0 |
0.1 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 0.0 |
0.0 |
GO:0045763 |
regulation of glutamine family amino acid metabolic process(GO:0000820) negative regulation of cellular amino acid metabolic process(GO:0045763) regulation of glutamate metabolic process(GO:2000211) |
| 0.0 |
0.7 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
1.1 |
GO:0070286 |
axonemal dynein complex assembly(GO:0070286) |
| 0.0 |
0.4 |
GO:0070167 |
regulation of biomineral tissue development(GO:0070167) |
| 0.0 |
0.4 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.0 |
0.0 |
GO:0006844 |
acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.0 |
0.0 |
GO:0030205 |
dermatan sulfate metabolic process(GO:0030205) |
| 0.0 |
0.1 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.0 |
0.5 |
GO:0048255 |
RNA stabilization(GO:0043489) mRNA stabilization(GO:0048255) |
| 0.0 |
0.0 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.0 |
0.2 |
GO:0055059 |
asymmetric neuroblast division(GO:0055059) |
| 0.0 |
0.3 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.0 |
0.1 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.0 |
0.0 |
GO:0045629 |
negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.0 |
0.1 |
GO:0007501 |
mesodermal cell fate specification(GO:0007501) |
| 0.0 |
0.1 |
GO:0035624 |
receptor transactivation(GO:0035624) |
| 0.0 |
0.1 |
GO:0097029 |
mature conventional dendritic cell differentiation(GO:0097029) |
| 0.0 |
0.0 |
GO:1903351 |
response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.0 |
0.1 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
| 0.0 |
0.2 |
GO:0008212 |
mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.0 |
0.7 |
GO:0046710 |
GDP metabolic process(GO:0046710) |
| 0.0 |
0.2 |
GO:1990502 |
dense core granule maturation(GO:1990502) |
| 0.0 |
0.4 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
| 0.0 |
0.2 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.0 |
0.3 |
GO:0051155 |
positive regulation of striated muscle cell differentiation(GO:0051155) |
| 0.0 |
0.1 |
GO:0051503 |
adenine nucleotide transport(GO:0051503) |
| 0.0 |
0.2 |
GO:1990034 |
calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
| 0.0 |
0.0 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.0 |
3.4 |
GO:0072332 |
intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.0 |
0.7 |
GO:0032786 |
positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.0 |
0.2 |
GO:2000758 |
positive regulation of histone acetylation(GO:0035066) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
| 0.0 |
0.2 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.0 |
0.2 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.0 |
0.8 |
GO:0006068 |
ethanol catabolic process(GO:0006068) |
| 0.0 |
0.1 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.0 |
0.1 |
GO:0051573 |
negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.0 |
0.1 |
GO:0007518 |
myoblast fate determination(GO:0007518) |
| 0.0 |
0.2 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.0 |
0.3 |
GO:0031069 |
hair follicle morphogenesis(GO:0031069) |
| 0.0 |
0.6 |
GO:1900745 |
positive regulation of p38MAPK cascade(GO:1900745) |
| 0.0 |
0.2 |
GO:0048749 |
compound eye development(GO:0048749) |
| 0.0 |
0.2 |
GO:0015860 |
purine nucleoside transmembrane transport(GO:0015860) |
| 0.0 |
1.1 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.0 |
0.1 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.0 |
0.1 |
GO:0070781 |
response to biotin(GO:0070781) |
| 0.0 |
0.4 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.0 |
0.1 |
GO:0035234 |
ectopic germ cell programmed cell death(GO:0035234) |
| 0.0 |
0.3 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.0 |
0.1 |
GO:0010332 |
response to gamma radiation(GO:0010332) |
| 0.0 |
0.1 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.0 |
0.0 |
GO:2000254 |
regulation of male germ cell proliferation(GO:2000254) |
| 0.0 |
0.7 |
GO:0097502 |
mannosylation(GO:0097502) |
| 0.0 |
0.1 |
GO:0010042 |
response to manganese ion(GO:0010042) |
| 0.0 |
0.6 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.0 |
0.4 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.0 |
0.0 |
GO:0046618 |
drug export(GO:0046618) |
| 0.0 |
0.0 |
GO:1902993 |
positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
| 0.0 |
0.0 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability(GO:0035795) negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.0 |
0.2 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.0 |
0.1 |
GO:0051220 |
cytoplasmic sequestering of protein(GO:0051220) |
| 0.0 |
0.0 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.0 |
0.1 |
GO:0046689 |
response to mercury ion(GO:0046689) |
| 0.0 |
0.1 |
GO:0032509 |
endosome transport via multivesicular body sorting pathway(GO:0032509) |
| 0.0 |
1.2 |
GO:0006119 |
oxidative phosphorylation(GO:0006119) |
| 0.0 |
0.1 |
GO:0048368 |
lateral mesoderm development(GO:0048368) |
| 0.0 |
0.7 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.0 |
0.2 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.0 |
0.2 |
GO:0050996 |
positive regulation of lipid catabolic process(GO:0050996) |
| 0.0 |
0.6 |
GO:0000052 |
citrulline metabolic process(GO:0000052) |
| 0.0 |
0.3 |
GO:0060287 |
epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.0 |
2.6 |
GO:0010811 |
positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.0 |
0.2 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.0 |
0.7 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.0 |
0.6 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 |
0.4 |
GO:1902913 |
positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.0 |
0.0 |
GO:0034770 |
histone H4-K20 methylation(GO:0034770) |
| 0.0 |
0.1 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.0 |
0.1 |
GO:0002384 |
hepatic immune response(GO:0002384) |
| 0.0 |
0.1 |
GO:0010286 |
heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.0 |
0.1 |
GO:0002581 |
negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 0.0 |
0.1 |
GO:1903778 |
protein localization to vacuolar membrane(GO:1903778) |
| 0.0 |
0.2 |
GO:2000269 |
regulation of fibroblast apoptotic process(GO:2000269) |
| 0.0 |
0.6 |
GO:0070498 |
interleukin-1-mediated signaling pathway(GO:0070498) |
| 0.0 |
1.0 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.0 |
0.0 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.0 |
0.1 |
GO:0035864 |
response to potassium ion(GO:0035864) |
| 0.0 |
0.1 |
GO:0010288 |
response to lead ion(GO:0010288) |
| 0.0 |
0.2 |
GO:0048863 |
stem cell differentiation(GO:0048863) |
| 0.0 |
0.1 |
GO:0099624 |
atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.0 |
0.5 |
GO:0035914 |
skeletal muscle cell differentiation(GO:0035914) |
| 0.0 |
1.8 |
GO:0001510 |
RNA methylation(GO:0001510) |
| 0.0 |
0.1 |
GO:0035897 |
proteolysis in other organism(GO:0035897) |
| 0.0 |
0.6 |
GO:0035082 |
axoneme assembly(GO:0035082) |
| 0.0 |
0.1 |
GO:1901143 |
insulin catabolic process(GO:1901143) |
| 0.0 |
0.1 |
GO:0046719 |
regulation by virus of viral protein levels in host cell(GO:0046719) |
| 0.0 |
0.4 |
GO:1903393 |
positive regulation of adherens junction organization(GO:1903393) |
| 0.0 |
0.1 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
| 0.0 |
0.0 |
GO:1904562 |
phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.0 |
0.2 |
GO:0060039 |
pericardium development(GO:0060039) |
| 0.0 |
0.0 |
GO:0000963 |
mitochondrial RNA processing(GO:0000963) |
| 0.0 |
0.1 |
GO:0048485 |
sympathetic nervous system development(GO:0048485) |
| 0.0 |
0.1 |
GO:0002447 |
eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
| 0.0 |
0.1 |
GO:0048713 |
regulation of oligodendrocyte differentiation(GO:0048713) |
| 0.0 |
0.0 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
| 0.0 |
0.4 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.0 |
0.3 |
GO:1900004 |
negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.0 |
0.2 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.0 |
0.3 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
0.1 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.0 |
0.3 |
GO:0035826 |
rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.0 |
0.2 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.0 |
2.8 |
GO:1903955 |
positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.0 |
0.0 |
GO:0015988 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) |
| 0.0 |
0.0 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.0 |
0.1 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.0 |
0.2 |
GO:1900746 |
regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
| 0.0 |
0.1 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.0 |
0.2 |
GO:0031998 |
regulation of fatty acid beta-oxidation(GO:0031998) |
| 0.0 |
0.0 |
GO:0086100 |
endothelin receptor signaling pathway(GO:0086100) |
| 0.0 |
0.2 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.0 |
0.1 |
GO:0002881 |
microglial cell activation involved in immune response(GO:0002282) negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) negative regulation of long-term synaptic potentiation(GO:1900272) |
| 0.0 |
0.2 |
GO:0060292 |
long term synaptic depression(GO:0060292) |
| 0.0 |
0.1 |
GO:0042700 |
luteinizing hormone signaling pathway(GO:0042700) |
| 0.0 |
0.2 |
GO:0017004 |
cytochrome complex assembly(GO:0017004) |
| 0.0 |
0.2 |
GO:0045007 |
depurination(GO:0045007) |
| 0.0 |
0.1 |
GO:0090675 |
intermicrovillar adhesion(GO:0090675) |
| 0.0 |
0.1 |
GO:0045839 |
negative regulation of mitotic nuclear division(GO:0045839) |
| 0.0 |
0.1 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.0 |
0.0 |
GO:0090280 |
positive regulation of calcium ion import(GO:0090280) |
| 0.0 |
0.2 |
GO:0032462 |
regulation of protein homooligomerization(GO:0032462) |
| 0.0 |
0.1 |
GO:0043029 |
T cell homeostasis(GO:0043029) |
| 0.0 |
0.5 |
GO:0045616 |
regulation of keratinocyte differentiation(GO:0045616) |
| 0.0 |
0.1 |
GO:0051569 |
regulation of histone H3-K4 methylation(GO:0051569) |
| 0.0 |
0.0 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.0 |
0.1 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.0 |
0.3 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 |
0.0 |
GO:0018342 |
protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.0 |
0.2 |
GO:0030279 |
negative regulation of ossification(GO:0030279) |
| 0.0 |
0.1 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.0 |
0.1 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.0 |
0.2 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.0 |
0.6 |
GO:0051602 |
response to electrical stimulus(GO:0051602) |
| 0.0 |
0.1 |
GO:0099640 |
axo-dendritic protein transport(GO:0099640) |
| 0.0 |
0.1 |
GO:0006612 |
protein targeting to membrane(GO:0006612) |
| 0.0 |
0.2 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.0 |
0.2 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.0 |
0.1 |
GO:0006356 |
regulation of transcription from RNA polymerase I promoter(GO:0006356) |
| 0.0 |
0.1 |
GO:0006406 |
mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.0 |
0.1 |
GO:0039656 |
modulation by virus of host gene expression(GO:0039656) |
| 0.0 |
0.1 |
GO:0009304 |
tRNA transcription(GO:0009304) |
| 0.0 |
0.3 |
GO:0010744 |
positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
| 0.0 |
0.1 |
GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
| 0.0 |
0.5 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.0 |
0.5 |
GO:1903205 |
regulation of hydrogen peroxide-induced cell death(GO:1903205) |
| 0.0 |
0.1 |
GO:0042357 |
thiamine diphosphate metabolic process(GO:0042357) |
| 0.0 |
0.8 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.0 |
0.0 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.0 |
0.5 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.0 |
0.1 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.0 |
0.2 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.0 |
0.1 |
GO:0036309 |
protein localization to M-band(GO:0036309) |
| 0.0 |
0.1 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.0 |
0.6 |
GO:0006099 |
tricarboxylic acid cycle(GO:0006099) |
| 0.0 |
0.1 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.0 |
0.1 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.0 |
0.1 |
GO:0001828 |
inner cell mass cellular morphogenesis(GO:0001828) |
| 0.0 |
0.3 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.0 |
0.1 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.0 |
1.5 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.0 |
0.2 |
GO:1905245 |
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) regulation of aspartic-type peptidase activity(GO:1905245) |
| 0.0 |
0.2 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.0 |
1.1 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.0 |
1.2 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 |
0.1 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
| 0.0 |
0.4 |
GO:0019373 |
epoxygenase P450 pathway(GO:0019373) |
| 0.0 |
0.1 |
GO:0023035 |
CD40 signaling pathway(GO:0023035) |
| 0.0 |
0.0 |
GO:0010644 |
cell communication by electrical coupling(GO:0010644) |
| 0.0 |
3.8 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 |
0.1 |
GO:0002644 |
negative regulation of tolerance induction(GO:0002644) |
| 0.0 |
0.9 |
GO:0007029 |
endoplasmic reticulum organization(GO:0007029) |
| 0.0 |
0.0 |
GO:0007584 |
response to nutrient(GO:0007584) |
| 0.0 |
0.5 |
GO:0042026 |
protein refolding(GO:0042026) |
| 0.0 |
1.0 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.0 |
0.4 |
GO:0042044 |
fluid transport(GO:0042044) |
| 0.0 |
0.2 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.0 |
0.0 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.0 |
0.0 |
GO:0002253 |
activation of immune response(GO:0002253) |
| 0.0 |
0.4 |
GO:0001516 |
prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.0 |
0.0 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.0 |
1.5 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.0 |
0.2 |
GO:0043152 |
induction of bacterial agglutination(GO:0043152) |
| 0.0 |
0.1 |
GO:2000870 |
regulation of progesterone secretion(GO:2000870) |
| 0.0 |
0.3 |
GO:0007595 |
lactation(GO:0007595) |
| 0.0 |
0.3 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.0 |
0.1 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.0 |
0.2 |
GO:0006687 |
glycosphingolipid metabolic process(GO:0006687) |
| 0.0 |
0.5 |
GO:0002755 |
MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.0 |
0.0 |
GO:0043652 |
engulfment of apoptotic cell(GO:0043652) |
| 0.0 |
0.1 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.0 |
0.4 |
GO:0010832 |
negative regulation of myotube differentiation(GO:0010832) |
| 0.0 |
0.1 |
GO:0051156 |
glucose 6-phosphate metabolic process(GO:0051156) |
| 0.0 |
0.0 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.0 |
0.1 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.0 |
0.1 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.0 |
0.1 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) |
| 0.0 |
0.0 |
GO:0098582 |
innate vocalization behavior(GO:0098582) |
| 0.0 |
0.0 |
GO:0043112 |
receptor metabolic process(GO:0043112) |
| 0.0 |
0.5 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) |
| 0.0 |
0.1 |
GO:0034982 |
mitochondrial protein processing(GO:0034982) |
| 0.0 |
0.0 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
| 0.0 |
0.2 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 |
0.4 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.0 |
0.0 |
GO:0009448 |
gamma-aminobutyric acid metabolic process(GO:0009448) |
| 0.0 |
0.2 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.0 |
0.2 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.0 |
0.1 |
GO:0031666 |
positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.0 |
0.2 |
GO:0035067 |
negative regulation of histone acetylation(GO:0035067) |
| 0.0 |
0.2 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.0 |
0.1 |
GO:2000535 |
regulation of entry of bacterium into host cell(GO:2000535) |
| 0.0 |
0.1 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
| 0.0 |
0.1 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.0 |
0.2 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.0 |
0.1 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.0 |
0.2 |
GO:0042987 |
amyloid precursor protein catabolic process(GO:0042987) |
| 0.0 |
0.2 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.0 |
0.1 |
GO:0021831 |
embryonic olfactory bulb interneuron precursor migration(GO:0021831) |
| 0.0 |
0.6 |
GO:0097031 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 |
0.0 |
GO:0035330 |
regulation of hippo signaling(GO:0035330) |
| 0.0 |
0.2 |
GO:0090199 |
regulation of release of cytochrome c from mitochondria(GO:0090199) |
| 0.0 |
0.1 |
GO:0010002 |
cardioblast differentiation(GO:0010002) |
| 0.0 |
0.2 |
GO:1901642 |
nucleoside transmembrane transport(GO:1901642) |
| 0.0 |
0.2 |
GO:0042551 |
neuron maturation(GO:0042551) |
| 0.0 |
0.1 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.0 |
0.3 |
GO:0046548 |
retinal rod cell development(GO:0046548) |
| 0.0 |
0.0 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.0 |
0.1 |
GO:0033137 |
negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.0 |
2.9 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 |
0.2 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.0 |
0.1 |
GO:0002884 |
negative regulation of type IV hypersensitivity(GO:0001808) negative regulation of hypersensitivity(GO:0002884) |
| 0.0 |
0.1 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.0 |
0.0 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.0 |
0.1 |
GO:0061760 |
antifungal innate immune response(GO:0061760) |
| 0.0 |
0.2 |
GO:0018202 |
peptidyl-histidine modification(GO:0018202) |
| 0.0 |
8.1 |
GO:0043687 |
post-translational protein modification(GO:0043687) |
| 0.0 |
0.1 |
GO:0031282 |
regulation of guanylate cyclase activity(GO:0031282) |
| 0.0 |
0.0 |
GO:0016572 |
histone phosphorylation(GO:0016572) |
| 0.0 |
0.2 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.0 |
0.3 |
GO:0003407 |
neural retina development(GO:0003407) |
| 0.0 |
0.1 |
GO:0006574 |
valine catabolic process(GO:0006574) |
| 0.0 |
0.2 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 |
0.1 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.0 |
0.1 |
GO:0020027 |
hemoglobin metabolic process(GO:0020027) |
| 0.0 |
0.0 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.0 |
0.0 |
GO:0030011 |
maintenance of cell polarity(GO:0030011) |
| 0.0 |
0.0 |
GO:0032105 |
negative regulation of response to extracellular stimulus(GO:0032105) negative regulation of response to nutrient levels(GO:0032108) |
| 0.0 |
0.0 |
GO:0045345 |
positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.0 |
0.1 |
GO:0019081 |
viral translation(GO:0019081) |
| 0.0 |
0.1 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.0 |
0.0 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.0 |
0.1 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.0 |
0.1 |
GO:0042832 |
defense response to protozoan(GO:0042832) |
| 0.0 |
0.1 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.0 |
0.3 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.0 |
0.0 |
GO:0060996 |
dendritic spine development(GO:0060996) |
| 0.0 |
0.1 |
GO:0001973 |
adenosine receptor signaling pathway(GO:0001973) |
| 0.0 |
0.0 |
GO:0042489 |
negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
| 0.0 |
0.1 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.0 |
0.1 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.0 |
0.1 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.0 |
0.0 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.0 |
0.1 |
GO:0060572 |
morphogenesis of an epithelial bud(GO:0060572) |
| 0.0 |
0.0 |
GO:1902576 |
regulation of telomere maintenance via semi-conservative replication(GO:0032213) negative regulation of telomere maintenance via semi-conservative replication(GO:0032214) negative regulation of nuclear cell cycle DNA replication(GO:1902576) |
| 0.0 |
0.1 |
GO:0002829 |
negative regulation of type 2 immune response(GO:0002829) |
| 0.0 |
0.2 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.0 |
0.1 |
GO:0044144 |
regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
| 0.0 |
0.3 |
GO:0039702 |
viral budding via host ESCRT complex(GO:0039702) |
| 0.0 |
0.1 |
GO:0035544 |
negative regulation of SNARE complex assembly(GO:0035544) |
| 0.0 |
0.1 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
0.2 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.0 |
0.2 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.0 |
0.2 |
GO:0009799 |
specification of symmetry(GO:0009799) |
| 0.0 |
0.1 |
GO:0044211 |
CTP salvage(GO:0044211) |
| 0.0 |
0.0 |
GO:0002693 |
positive regulation of cellular extravasation(GO:0002693) |
| 0.0 |
0.0 |
GO:1903670 |
regulation of sprouting angiogenesis(GO:1903670) |
| 0.0 |
0.0 |
GO:0032627 |
interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
| 0.0 |
0.3 |
GO:1990830 |
response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
| 0.0 |
0.0 |
GO:0006531 |
aspartate metabolic process(GO:0006531) |
| 0.0 |
0.9 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.0 |
0.0 |
GO:0006829 |
zinc II ion transport(GO:0006829) |
| 0.0 |
0.1 |
GO:2000059 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.0 |
0.1 |
GO:0002019 |
regulation of renal output by angiotensin(GO:0002019) |
| 0.0 |
0.0 |
GO:0035112 |
genitalia morphogenesis(GO:0035112) |
| 0.0 |
0.0 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.0 |
0.0 |
GO:0032402 |
melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
| 0.0 |
0.1 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.0 |
0.0 |
GO:0060122 |
inner ear receptor stereocilium organization(GO:0060122) |
| 0.0 |
0.0 |
GO:0007588 |
excretion(GO:0007588) |
| 0.0 |
0.2 |
GO:0090398 |
cellular senescence(GO:0090398) |
| 0.0 |
0.0 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.0 |
0.1 |
GO:1902894 |
negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.0 |
0.0 |
GO:0010626 |
regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.0 |
0.2 |
GO:1901071 |
glucosamine-containing compound metabolic process(GO:1901071) |
| 0.0 |
0.0 |
GO:0047497 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.0 |
0.2 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.0 |
0.2 |
GO:0048538 |
thymus development(GO:0048538) |
| 0.0 |
0.1 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.0 |
0.0 |
GO:0051292 |
pore complex assembly(GO:0046931) nuclear pore complex assembly(GO:0051292) |
| 0.0 |
0.4 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 0.0 |
0.1 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.0 |
0.6 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.0 |
0.1 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) |
| 0.0 |
0.4 |
GO:0070911 |
global genome nucleotide-excision repair(GO:0070911) |
| 0.0 |
0.1 |
GO:0032291 |
central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 0.0 |
0.1 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.0 |
0.3 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.0 |
0.2 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
| 0.0 |
0.0 |
GO:0006921 |
cellular component disassembly involved in execution phase of apoptosis(GO:0006921) |
| 0.0 |
0.1 |
GO:1902803 |
regulation of synaptic vesicle transport(GO:1902803) |
| 0.0 |
0.1 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.0 |
0.2 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.0 |
0.0 |
GO:0001707 |
mesoderm formation(GO:0001707) mesoderm morphogenesis(GO:0048332) |
| 0.0 |
0.0 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.0 |
0.1 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 |
0.1 |
GO:0002548 |
monocyte chemotaxis(GO:0002548) |
| 0.0 |
0.0 |
GO:1901725 |
regulation of histone deacetylase activity(GO:1901725) |
| 0.0 |
0.0 |
GO:0042634 |
regulation of hair cycle(GO:0042634) |
| 0.0 |
0.0 |
GO:0051966 |
regulation of synaptic transmission, glutamatergic(GO:0051966) |
| 0.0 |
0.0 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.0 |
0.1 |
GO:0035965 |
cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.0 |
0.0 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.0 |
0.2 |
GO:0021952 |
central nervous system projection neuron axonogenesis(GO:0021952) |
| 0.0 |
0.1 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.0 |
0.0 |
GO:0002011 |
morphogenesis of an epithelial sheet(GO:0002011) |
| 0.0 |
0.0 |
GO:0045777 |
positive regulation of blood pressure(GO:0045777) |
| 0.0 |
0.1 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.0 |
0.0 |
GO:0046968 |
peptide antigen transport(GO:0046968) |
| 0.0 |
0.0 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.0 |
0.1 |
GO:0006672 |
ceramide metabolic process(GO:0006672) |
| 0.0 |
0.1 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
| 0.0 |
0.1 |
GO:0010880 |
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
| 0.0 |
0.1 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.0 |
0.1 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.0 |
0.0 |
GO:0030309 |
poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 0.0 |
0.0 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.0 |
0.0 |
GO:0071360 |
cellular response to exogenous dsRNA(GO:0071360) |
| 0.0 |
0.0 |
GO:0038188 |
cholecystokinin signaling pathway(GO:0038188) |
| 0.0 |
0.0 |
GO:0090069 |
regulation of ribosome biogenesis(GO:0090069) |
| 0.0 |
0.0 |
GO:0070676 |
intralumenal vesicle formation(GO:0070676) |
| 0.0 |
0.0 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.0 |
0.0 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.0 |
0.0 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.0 |
0.0 |
GO:0070585 |
protein localization to mitochondrion(GO:0070585) |
| 0.0 |
0.1 |
GO:0052805 |
histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
| 0.0 |
0.1 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 |
0.0 |
GO:0002541 |
activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.0 |
0.2 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.0 |
0.0 |
GO:0015891 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.0 |
0.0 |
GO:1904430 |
negative regulation of t-circle formation(GO:1904430) |
| 0.0 |
0.0 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.0 |
0.0 |
GO:0033085 |
negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.0 |
0.2 |
GO:0034394 |
protein localization to cell surface(GO:0034394) |
| 0.0 |
0.1 |
GO:0070525 |
tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 0.0 |
0.1 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.0 |
0.0 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.0 |
0.4 |
GO:0006383 |
transcription from RNA polymerase III promoter(GO:0006383) |
| 0.0 |
0.1 |
GO:0000492 |
box C/D snoRNP assembly(GO:0000492) |
| 0.0 |
0.2 |
GO:0042462 |
eye photoreceptor cell development(GO:0042462) |
| 0.0 |
0.1 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.0 |
0.0 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
| 0.0 |
0.0 |
GO:0051295 |
establishment of meiotic spindle localization(GO:0051295) |
| 0.0 |
0.0 |
GO:0045919 |
positive regulation of cytolysis(GO:0045919) |
| 0.0 |
0.1 |
GO:0045589 |
regulation of regulatory T cell differentiation(GO:0045589) |
| 0.0 |
0.2 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.0 |
0.1 |
GO:0030166 |
proteoglycan biosynthetic process(GO:0030166) |
